Although VXUS is typically regarded as the gold standard, I'm becoming more interested in the growth potential of companies such as Novo Nordisk, famous for Ozempic, AstraZeneca, Novartis, and Toyota.
VXUS seems too diversified and diluted for my preferences.
I'm actively seeking an ETF with low fees that adopts a more targeted strategy, emphasizing a significant weighting towards the top 10, 50, 100, or 200 non-US companies.
Any suggestions?
Submitted May 06, 2024 at 02:14AM by AncientKey1976 https://ift.tt/k0s3noh